MAPT and Huntington disease: Another study focused on evaluating a novel assay for quantifying mutant huntingtin (mtHTT) in CSF but also performed analyses of NFL (n = 14) and tau (n = 24) including both premanifest gene expansion carriers and manifest HD patients.